Antimicrobials Overuse in COVID-19: A Silent Pandemic of Antimicrobial Resistance
Keywords:
Antimicrobial resistance, AMR, Covid-19 pandemic, irrational prescribing, antibiotic stewardship
Abstract
The COVID-19 epidemic has presented many treatment challenges to physicians due to the lack of specific effective medicines. The COVID-19 pandemic is also witnessing irrational antibiotic use. The aggressive use of several antibiotics for treatment of COVID-19, and its complications may lead to another pandemic of Antimicrobial Resistance (AMR). Limiting unnecessary antibiotic use in viral infections, like COVID-19, should be emphasized in antimicrobial stewardship programs.
References
1. Ministry of Health and Family Welfare [Internet] MoHFW | Home. [Cited 12 May 2021]. Available from https://mohfw. gov.in
2. World Health Organization [Internet] WHO Coronavirus (COVID-19). [Cited 12 May 2021]. Available from https:// www.who.int/emergencies/diseases/novel-coronavirus- 2019/question-and-answers-hub/q-a-detail/coronavirusdisease- covid-19
3. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020 Apr;87(4):281-86.
4. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020 Sep;17(9):543-58.
5. Mustafa L, Tolaj I, Baftiu N, Fejza H. Use of antibiotics in COVID-19 ICU patients. J Infect Dev Ctries. 2021;15:501-05.
6. Beović B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H. Antibiotic use in patients with COVID-19:
a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020 Nov 1;75(11):3386-90.
7. McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship. Lancet Glob Health. 2017 Nov; 5(11):e1075- e1076.
8. Iyengar K, Jain VK, Vaishya R. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):797-799.
9. Lucien MAB, Canarie MF, Kilgore PE, Jean-Denis G, Fénélon N, Pierre M, Cerpa M, Joseph GA, Maki G, Zervos MJ, Dely P, Boncy J, Sati H, Rio AD, Ramon-Pardo P. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Int J Infect Dis. 2021 Mar;104:250- 254.
10. World Health Organization [Internet] Coronavirus disease (COVID-19). 2020 October 12.[Cited 12 May 2021]. Available from https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/question-and-answers-hub/q-a-detail/ coronavirus-disease-covid-19
11. Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Sci Rep. 2021 Mar 4;11(1):5116.
12. Khurana S, Singh P, Sharad N, Kiro VV, Rastogi N, Lathwal A, Malhotra R, Trikha A, Mathur P. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian J Med Microbiol. 2021 Apr;39(2):147-153.
13. World Health Organization. Bulletin of the World Health Organization. 2020; 2020;98:442-442A.
14. World Health Organization [Internet] Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. 2017 October 13. [Cited 12 May 2021]. Available from https://www.who.int/medicines/areas/rational_ use/prioritization-of-pathogens/en/.
15. Ganguly N. Situation Analysis: Antibiotic Use and Resistance in India. 2011 October 13. [Cited 12 May 2021]. Available from https://cddep.org/wp-content/uploads/2017/06/indiareport- web_8.pdf.
2. World Health Organization [Internet] WHO Coronavirus (COVID-19). [Cited 12 May 2021]. Available from https:// www.who.int/emergencies/diseases/novel-coronavirus- 2019/question-and-answers-hub/q-a-detail/coronavirusdisease- covid-19
3. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020 Apr;87(4):281-86.
4. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020 Sep;17(9):543-58.
5. Mustafa L, Tolaj I, Baftiu N, Fejza H. Use of antibiotics in COVID-19 ICU patients. J Infect Dev Ctries. 2021;15:501-05.
6. Beović B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H. Antibiotic use in patients with COVID-19:
a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020 Nov 1;75(11):3386-90.
7. McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship. Lancet Glob Health. 2017 Nov; 5(11):e1075- e1076.
8. Iyengar K, Jain VK, Vaishya R. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):797-799.
9. Lucien MAB, Canarie MF, Kilgore PE, Jean-Denis G, Fénélon N, Pierre M, Cerpa M, Joseph GA, Maki G, Zervos MJ, Dely P, Boncy J, Sati H, Rio AD, Ramon-Pardo P. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Int J Infect Dis. 2021 Mar;104:250- 254.
10. World Health Organization [Internet] Coronavirus disease (COVID-19). 2020 October 12.[Cited 12 May 2021]. Available from https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/question-and-answers-hub/q-a-detail/ coronavirus-disease-covid-19
11. Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Sci Rep. 2021 Mar 4;11(1):5116.
12. Khurana S, Singh P, Sharad N, Kiro VV, Rastogi N, Lathwal A, Malhotra R, Trikha A, Mathur P. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian J Med Microbiol. 2021 Apr;39(2):147-153.
13. World Health Organization. Bulletin of the World Health Organization. 2020; 2020;98:442-442A.
14. World Health Organization [Internet] Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. 2017 October 13. [Cited 12 May 2021]. Available from https://www.who.int/medicines/areas/rational_ use/prioritization-of-pathogens/en/.
15. Ganguly N. Situation Analysis: Antibiotic Use and Resistance in India. 2011 October 13. [Cited 12 May 2021]. Available from https://cddep.org/wp-content/uploads/2017/06/indiareport- web_8.pdf.
Published
2021-05-27
How to Cite
Dr. Apoorva Mathur, Prof. Y.K. Gupta. (2021). Antimicrobials Overuse in COVID-19: A Silent Pandemic of Antimicrobial Resistance. The Indian Practitioner, 74(5), 28-31. Retrieved from http://articles.theindianpractitioner.com/index.php/tip/article/view/1167
Section
Commentary
